Skip to search formSkip to main contentSkip to account menu

glimepiride 2 MG / pioglitazone 30 MG Oral Tablet

Known as: glimepiride 2 MG / pioglitazone (as pioglitazone hydrochloride) 30 MG Oral Tablet, GLIMEPIRIDE 2MG/PIOGLITAZONE HCL 30MG TAB, GLIMEPIRIDE 2MG/PIOGLITAZONE HCL 30MG TAB [VA Product] 
National Institutes of Health

Related topics

Related topics

12 relations
Croscarmellose SodiumLactose MonohydrateMagnesium stearateOral Tablet

Narrower (1)

glimepiride 2 MG / pioglitazone 30 MG Oral Tablet [Duetact]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Formulation and evaluation of microencapsulated Glimepiride produced by the emulsion - solvent evaporation method
The objective of the present investigation was to formulate and evaluate microencapsulated Glimepiride produced by the emulsion… 
2015
2015
IN VITRO EVALUATION OF THE PHARMACOKINETIC ALTERATIONS CAUSED BY SULFAMETHOXAZOLE ON GLIMEPIRIDE HYDROXYLATION: PREDICTION OF THE IN VIVO DRUG DRUG INTERACTION FROM IN VITRO DATA.
2012
2012
Diabetes: Choosing a second-line therapy after metformin in type 2 diabetes mellitus
2010
2010
Sitagliptin compared with the Sulfonylurea Glimepiride provides similar efficacy with less Hypoglycemia and no weight gain when added to ongoing Metformin therapy in patients with Type 2 Diabetes…
2010
2010
糖尿病治療薬 glimepiride の正常および糖尿病モデルラットを用いたPK/PD解析
2008
2008
Observation of Therapeutic Effects of Combination Therapy of Bedtime Insulin(NPH)and Glimepiride on Type 2 Diabetic Mellitus with Secondary Failure of Sulfonylurea
Objective:To observe the clinical efficacy of combination therapy of glimepiride and bedtime insulin(NPH)on type 2 diabetic… 
2004
2004
[Preparation and evaluation in vivo and in vitro of glimepiride gel-matrix controlled-release patch].
AIM To study the pharmaceutical characterization, the pharmacokinetics and relative bioavailability of glimepiride gel-matrix… 
2001
2001
Nicorandil, a K-ATP channel opener causes mitochondrial membrane depolarisation which is inhibited by the sulphonylurea glibenclamide but not by the sulphonylurea glimepiride.
1998
1998
Propriétés pharmacologiques du glimépiride
AbstractPharmacological Properties of Glimepiride: Rationale for Clinical Use in Type 2 DiabetesThe sulphonylurea glimepiride is… 
1995
1995
Glimepiride (HOE490) の膵外作用 -肝ブドウ糖取り込みに及ぼす glimepiride 1週間反復経口投与の効果-
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)